[{"Assets_0_Q2_USD":5898496000.0,"CIK":"1048477","CommonStockSharesConverted_0_Q2_shares":183321820.0,"CommonStockSharesOutstanding_0_Q2_shares":183321820.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":0.07,"EarningsPerShareBasic_2_Q2_USD":0.17,"EarningsPerShareDiluted_1_Q2_USD":0.07,"EarningsPerShareDiluted_2_Q2_USD":0.16,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":196296000.0,"NetIncomeLossConverted_1_Q2_USD":12941000.0,"NetIncomeLossConverted_2_Q2_USD":30312000.0,"OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q2_USD":501693000.0,"RevenuesConverted_2_Q2_USD":987723000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":4241571000.0,"Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":185427000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":185089000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":182844000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":182311000.0,"filed":"20210730","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2021.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20210630","qtrs":"0","uom":"USD"}]